Laboratory SaaS provider Labforward ramps up Series B financing to >EUR8.5 million in second closing
Berlin, 05/04/2021: With the successful completion of a second closing, Labforward adds >EUR3m to the Series B from January, bringing the total funds raised to >EUR8.5m. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name that serves its 27m customers across 15 European markets with eyewear and hearing aids.
Labforward has completed a second closing for its Series B. The family office of the Fielmann family, the existing investor IBB Ventures as well as existing and new business angels invest in the laboratory software company with headquarters in Berlin, Germany.